Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Disclosures
Jonathan S. Zager received research funding from Amgen, Castle Biosciences, Delcath Systems, Novartis, Provectus, and Philogen; serves on the medical advisory board for Delcath Systems, is a member of the speakers’ bureau for Sun Pharma and Pfizer; and is a consultant for Merck, Sanofi/Regeneron, Amgen, and Castle Biosciences. John T. Vetto is a speaker for Castle Biosciences. The remaining authors have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Dale Han: Deceased
Rights and permissions
About this article
Cite this article
Morrison, S., Han, G., Elenwa, F. et al. ASO Visual Abstract: Is There a Relationship Between Tumor-Infiltrating Lymphocytes (TILs) and Regression in Melanoma?. Ann Surg Oncol 29, 2869–2870 (2022). https://doi.org/10.1245/s10434-021-11300-7
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11300-7